Klausner Case Study

    Case Study: Point-of-care testing to increase HIV and HCV batch testing

    The Health Betterment Initiative and The Chris Atwood Foundation pilot outreach project significantly increased HIV and HCV testing among substance-using communities at high risk for co-infection.

    The OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and OraQuick® HCV Rapid Antibody Test allow for 2 test results with 1 fingerstick from each participant in an easy-to-use, 20-minute batch-testing workflow.

    "We find the 20 minutes is so important for connecting with participants. It's such a valuable piece of time in terms of linking people to care if they need it or educating them on prevention." -Sandra Marrero-Ashford, MPA, MPH, MA, CEO of HBI

    This study took place January 2024 - June 2024 and resulted in 1 HIV positive identified and linked to care. HBI continues to conduct testing with The Chris Atwood Foundation.

    Learn how harm reduction and healthcare partnerships work together to aid recovery, starting with these rapid tests.

    Interested in learning more about our rapid testing solutions for HCV, HIV, and/or Syphilis?

    Fill out this form and we will get back to you shortly.

    © OraSure Technologies Inc., 2025